Zhejiang Jingxin Pharmaceutical Co Ltd Cash Flow Quality Index
Zhejiang Jingxin Pharmaceutical Co Ltd cash flow quality index. Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Cash Flow Quality Index of 1.21x as of September 2025. Operating cash flow of CN¥227.64 Million exceeds net income of CN¥187.73 Million, indicating high earnings quality where cash backs reported profits. See 002020 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)
Cash flow quality index of Zhejiang Jingxin Pharmaceutical Co Ltd from 2002 to 2025. Historical Cash Flow Quality Index for Zhejiang Jingxin Pharmaceutical Co Ltd across 23 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Zhejiang Jingxin Pharmaceutical Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Zhejiang Jingxin Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2002–2025)
Zhejiang Jingxin Pharmaceutical Co Ltd cash flow quality index by year from 2002 to 2025. Year-by-year earnings quality comparison for Zhejiang Jingxin Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 002020 cash flow metrics.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.03x | CN¥781.35 Million | CN¥757.98 Million | ▲ +2.1% |
| 2024 | 1.01x | CN¥726.16 Million | CN¥719.13 Million | ▼ -23.7% |
| 2023 | 1.32x | CN¥824.69 Million | CN¥623.42 Million | ▲ +3.2% |
| 2022 | 1.28x | CN¥855.78 Million | CN¥667.82 Million | ▲ +115.8% |
| 2021 | 0.59x | CN¥365.02 Million | CN¥614.70 Million | ▼ -24.4% |
| 2020 | 0.79x | CN¥513.21 Million | CN¥653.33 Million | ▼ -23.4% |
| 2019 | 1.03x | CN¥535.30 Million | CN¥521.95 Million | ▼ -27.2% |
| 2018 | 1.41x | CN¥523.40 Million | CN¥371.49 Million | ▼ -2.3% |
| 2017 | 1.44x | CN¥385.01 Million | CN¥267.03 Million | ▲ +23.7% |
| 2016 | 1.17x | CN¥252.69 Million | CN¥216.73 Million | ▲ +34.3% |
| 2015 | 0.87x | CN¥144.69 Million | CN¥166.62 Million | ▼ -55.8% |
| 2014 | 1.97x | CN¥210.49 Million | CN¥107.08 Million | ▲ +13.9% |
| 2013 | 1.73x | CN¥111.03 Million | CN¥64.35 Million | ▼ -9.3% |
| 2012 | 1.90x | CN¥60.28 Million | CN¥31.68 Million | ▼ -20.2% |
| 2011 | 2.38x | CN¥69.41 Million | CN¥29.12 Million | ▼ -48.1% |
| 2010 | 4.59x | CN¥59.55 Million | CN¥12.96 Million | ▼ -86.5% |
| 2009 | 34.09x | CN¥135.38 Million | CN¥3.97 Million | ▲ +156.6% |
| 2007 | -60.25x | CN¥-87.60 Million | CN¥1.45 Million | ▼ -43530.9% |
| 2006 | -0.14x | CN¥-1.45 Million | CN¥10.47 Million | ▼ -104.1% |
| 2005 | 3.35x | CN¥61.82 Million | CN¥18.45 Million | ▲ +1243.6% |
| 2004 | 0.25x | CN¥6.43 Million | CN¥25.79 Million | ▼ -86.3% |
| 2003 | 1.82x | CN¥46.18 Million | CN¥25.40 Million | ▼ -11.0% |
| 2002 | 2.04x | CN¥45.50 Million | CN¥22.28 Million | — |